Skip to content
  • Home
  • About us
    • Our Team
    • Scientific Advisors
    • Our Product Pipeline
  • Science
    • AMD and Eyecyte-RPETM
    • Retinitis pigmentosa and Eyecyte-PRPTM
  • Publications
  • Resources
    • News and Media
    • Recognition
    • Collaborations
    • Research Alliance
  • Careers
  • Contact Us
Eyestem
  • Home
  • About us
    • Our Team
    • Scientific Advisors
    • Our Product Pipeline
  • Science
    • AMD and Eyecyte-RPETM
    • Retinitis pigmentosa and Eyecyte-PRPTM
  • Publications
  • Resources
    • News and Media
    • Recognition
    • Collaborations
    • Research Alliance
  • Careers
  • Contact Us

Archives: home_banner

Holds our home_banner data

  • Home
  • home_banner

Eyestem files for IND approval for its product to treat Geographic Atrophy, the largest cause of incurable blindness in the world for people over 50

Learn More

Eyestem bags the top innovator award in the country across all categories at the prestigious Economic Times awards

Learn More

Eyestem announces US operations with appointment of Ravi Achar and engagement of Stradling advisors

Learn More

Eyestem raises Series A round from Biological E, Alkem, NATCO, Kemwell promoters and existing investors- Kotak and Endiya

Learn More

Eyestem announces award of its US patent

 

Learn More

Developing scalable cell replacement therapies for the world

Learn More

Endiya Partners invest in Cell Therapy Company Eyestem

Learn More

Eyestem achieves

Learn More

Eyestem awarded

a

Learn More
  • About Us
  • Science
  • Publications
  • Collaborations
  • Updates
  • Careers
  • Contact Us
  • Sitemap
Copyright© 2023 - Eyestem Research Pvt Ltd
  • Follow Us